In vitro evaluation of novel inhalable dry powders consisting of thioridazine and rifapentine for rapid tuberculosis treatment. (Record no. 26232533)

MARC details
000 -LEADER
fixed length control field 01524 a2200373 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250517104929.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201703s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1873-3441
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1016/j.ejpb.2016.07.014
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Parumasivam, T
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20170310
245 00 - TITLE STATEMENT
Title In vitro evaluation of novel inhalable dry powders consisting of thioridazine and rifapentine for rapid tuberculosis treatment.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
Date of publication, distribution, etc. Oct 2016
300 ## - PHYSICAL DESCRIPTION
Extent 205-14 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Administration, Inhalation
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antitubercular Agents
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element In Vitro Techniques
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Powder Diffraction
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Powders
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Rifampin
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Thioridazine
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Tuberculosis
General subdivision drug therapy
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Chan, J G Y
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Pang, A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Quan, D H
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Triccas, J A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Britton, W J
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Chan, H K
773 0# - HOST ITEM ENTRY
Title European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
Related parts vol. 107
-- p. 205-14
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1016/j.ejpb.2016.07.014">https://doi.org/10.1016/j.ejpb.2016.07.014</a>
Public note Available from publisher's website

No items available.